Cognition Thought Leadership
Conversations: Fireside Video Chats
The new “Conversations” video series will feature virtual fireside chats with neuroscience experts who will discuss advances in the research and treatment of Alzheimer’s disease, dementia with Lewy bodies (DLB), and other age-related neurodegenerative conditions. Please use the form at the bottom of our webpage you submit your comments or feedback.
Episode 2: Building on Amyloid Lowering: Key Insights from Recent Data and Prospects for Complementary Therapeutic Approaches
| Featuring: | ||
| Anthony Caggiano, M.D., Ph.D. | Cognition’s Chief Medical Officer and Head of R&D |  |
| Christopher H. van Dyck, M.D. | Yale University School of Medicine Professor of Psychiatry, Neurology, and Neuroscience; Director of the Yale School of Medicine Division of Aging and Geriatric Psychiatry; and Director of the Alzheimer’s Disease Research Center | |
| Anton P. Porsteinsson, M.D. | University of Rochester School of Medicine and Dentistry William B. and Sheila Konar Professor of Psychiatry, Neurology, Neuroscience, and Medicine; and Director of the Alzheimer’s Disease Care, Research and Education Program (AD-CARE) | |
Episode 1: Dementia with Lewy Bodies
| Featuring: | ||
| Anthony Caggiano, M.D., Ph.D. | Cognition’s Chief Medical Officer and Head of R&D |  |
| James Galvin, M.D., MPH | Director of the Comprehensive Center for Brain Health University of Miami Miller School of Medicine Principal investigator of the SHIMMER clinical trial |
|
Leadership Editorials
By Lisa Ricciardi
October 1, 2022
Questions? Send us an email:
Social Media
Major validation in @NEJM of our approach at @CogRx protecting brain cells from toxic #oligomers. Decades of work into #amyloid paying off, as researchers now target oligomers as key neurotoxin. Moving the needle for #AlzheimersDisease patients. https://www.nejm.org/doi/full/10.1056/NEJMe2214981 $CGTX